These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36040392)

  • 1. Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic.
    Sahoo P; Dey J; Mahapatra SR; Ghosh A; Jaiswal A; Padhi S; Prabhuswamimath SC; Misra N; Suar M
    OMICS; 2022 Sep; 26(9):473-488. PubMed ID: 36040392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
    Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Nanotechnology in the COVID-19 Pandemic.
    Yang D
    Int J Nanomedicine; 2021; 16():623-649. PubMed ID: 33531805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.
    Rahman MM; Ahmed M; Islam MT; Khan MR; Sultana S; Maeesa SK; Hasan S; Hossain MA; Ferdous KS; Mathew B; Rauf A; Uddin MS
    Curr Pharm Des; 2022; 28(12):948-968. PubMed ID: 34218774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.
    Varahachalam SP; Lahooti B; Chamaneh M; Bagchi S; Chhibber T; Morris K; Bolanos JF; Kim NY; Kaushik A
    Int J Nanomedicine; 2021; 16():539-560. PubMed ID: 33519200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
    Rai M; Bonde S; Yadav A; Plekhanova Y; Reshetilov A; Gupta I; Golińska P; Pandit R; Ingle AP
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1299-1308. PubMed ID: 33164589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19.
    Bhattacharjee A; Saha M; Halder A; Debnath A; Mukherjee O
    Curr Microbiol; 2021 Feb; 78(2):435-448. PubMed ID: 33392670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Virology of SARS-CoV-2 and Related Coronaviruses.
    Kung YA; Lee KM; Chiang HJ; Huang SY; Wu CJ; Shih SR
    Microbiol Mol Biol Rev; 2022 Jun; 86(2):e0002621. PubMed ID: 35343760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges.
    Yang X; Liu Y; Liu Y; Yang Q; Wu X; Huang X; Liu H; Cai W; Ma G
    Expert Rev Clin Pharmacol; 2020 Sep; 13(9):957-975. PubMed ID: 32746653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology-based strategies against SARS-CoV-2 variants.
    Huang X; Kon E; Han X; Zhang X; Kong N; Mitchell MJ; Peer D; Tao W
    Nat Nanotechnol; 2022 Oct; 17(10):1027-1037. PubMed ID: 35982317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic.
    Kumar R; Harilal S; Al-Sehemi AG; Mathew GE; Carradori S; Mathew B
    Curr Med Chem; 2021; 28(15):2852-2886. PubMed ID: 32614740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research and Patents on Coronavirus and COVID-19: A Review.
    Aranda P; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Darder M; Del Real G; Ruiz-Hitzky E
    Recent Pat Nanotechnol; 2020; 14(4):328-350. PubMed ID: 33087037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
    Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
    J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view.
    Chatterjee S; Mishra S; Chowdhury KD; Ghosh CK; Saha KD
    Life Sci; 2021 Aug; 278():119580. PubMed ID: 33991549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
    Hasanzadeh A; Alamdaran M; Ahmadi S; Nourizadeh H; Bagherzadeh MA; Mofazzal Jahromi MA; Simon P; Karimi M; Hamblin MR
    J Control Release; 2021 Aug; 336():354-374. PubMed ID: 34175366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Utility of Radiopharmaceuticals in the Battle Against SARSCov- 2 and COVID-19 Pandemic.
    Sager O; Dincoglan F; Demiral S; Beyzadeoglu M
    Curr Radiopharm; 2022; 15(2):93-95. PubMed ID: 34635047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.